ping an-杏耀平台代理注册

in march 2011, the high standard edaravone raw materials and injection developed by c&o was approved by sfda. edaravone is a neuroprotective agent, used to improve neurological symptoms, activities of daily living and functional impairment due to acute cerebral infarction.